Zavesca and epilepsy Patient Reports February 10, 2010

Zavesca Side Effects Report #5081964-2
Zavesca side effect was reported by a Physician from ITALY on July 28, 2006. Female patient, child 12 years of age, weighting 90.39 lb, was diagnosed with niemann-pick disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: convulsion, dysphagia, epilepsy . Zavesca dosage: 400 MG, TID, ORAL. Patient was hospitalized and became disabled. Patient recovered.

Zavesca Side Effects Report #5154410-8
Zavesca side effect was reported by a Physician from ITALY on Oct 31, 2006. Female patient, child 12 years of age, weighting 90.39 lb, was diagnosed with niemann-pick disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: convulsion, dysphagia, epilepsy , tremor. Zavesca dosage: 100 MG QD ORAL. Patient was hospitalized and became disabled. Patient recovered.

Zavesca Side Effects Report #5319705-3
Zavesca side effect was reported by a Physician from FRANCE on Apr 20, 2007. Female patient, 17 years of age, weighting 106.9 lb, was diagnosed with gaucher's disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: acquired claw toe, chronic inflammatory demyelinating polyradiculoneuropathy, condition aggravated, diarrhoea, epilepsy , flatulence, guillain-barre syndrome , joint sprain. Zavesca dosage: 100 MG, TID, ORAL. During the same period patient was treated with LAMICTAL, TOPIRAMATE, CLONAZEPAM, KEPPRA. Patient was hospitalized. Patient recovered.

Zavesca Side Effects Report #5122624-9
Zavesca side effect was reported by a Consumer or non-health professional from FRANCE on Sept 21, 2006. Female patient, 17 years of age, weighting 106.9 lb, was diagnosed with gaucher's disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: acquired claw toe, chitotriosidase decreased, condition aggravated, demyelinating polyneuropathy, diarrhoea, epilepsy , flatulence, guillain-barre syndrome , joint sprain. Zavesca dosage: 100 MG, TID, ORAL; 100 MG, QD, ORAL. During the same period patient was treated with LAMICTAL, TOPIRAMATE, CLONAZEPAM, KEPPRA. Patient was hospitalized. Patient recovered.


Zavesca Side Effects Report #5521881-4
Zavesca side effect was reported by a Physician from FRANCE on Oct 31, 2007. Female patient, 17 years of age, weighting 106.9 lb, was diagnosed with gaucher's disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: condition aggravated, demyelinating polyneuropathy, diarrhoea, epilepsy , flatulence, foot fracture, guillain-barre syndrome , joint sprain, neuropathy peripheral. Zavesca dosage: 100 MG, TID, ORAL; 100 MG, QD, ORAL. During the same period patient was treated with LAMICTAL, TOPIRAMATE, CLONAZEPAM, KEPPRA. Patient was hospitalized. Patient recovered.

Zavesca Side Effects Report #4777912-2
Zavesca side effect was reported by a Consumer or non-health professional from FRANCE on Sept 05, 2005. Female patient, 17 years of age, weighting 106.9 lb, was diagnosed with gaucher's disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: condition aggravated, demyelinating polyneuropathy, epilepsy , guillain-barre syndrome , paraesthesia. Zavesca dosage: unknown. During the same period patient was treated with LAMCAL, TOPIRAMATE, CLONAZEPAM, KEPPRA. Patient was hospitalized. Patient recovered.

Zavesca Side Effects Report #4824677-1
Zavesca side effect was reported by a Consumer or non-health professional from FRANCE on Oct 17, 2005. Female patient, 17 years of age, weighting 106.9 lb, was diagnosed with gaucher's disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: acquired claw toe, condition aggravated, demyelinating polyneuropathy, diarrhoea, epilepsy , flatulence, guillain-barre syndrome . Zavesca dosage: 100 MG, TID, ORAL. During the same period patient was treated with LAMICTAL, TOPIRAMATE, CLONAZEPAM, KEPPRA. Patient was hospitalized. Patient recovered.